Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Chelsea and Westminster Hospital, United States Department of Veterans Affairs, VA Palo Alto Health Care System, Stanford University, Quest Clinical Research (United States), Hôpitaux Universitaires Henri-Mondor, University of California, Los Angeles, Los Angeles Medical Center, Northwestern University, University of California Davis Medical Center, University of California, Davis, University of Alabama, University of Alabama at Birmingham, University Hospitals of Cleveland, Case Western Reserve University, Rush University Medical Center
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1978179130